Replication-backed papers, especially with transparent methods, offer stronger guidance for future lab design
A 2025 regulatory analysis by Hurley and Frier at Frier Levitt outlined the practical implications: legitimate medical access to many peptides continues, but the sourcing pathway matters more than ever, and the clinician's knowledge of the current regulatory status of each specific compound is a prerequisite for appropriate prescribing
For general wellness, a common schedule is getting an injection anywhere from once a week to once a month
Look for this as an added ingredient it is a good sign that the manufacturer is thinking about bioavailability, not just label claims
Dahl, Kirsten
GHK-Cu has the advantage when considering the overall amount of research involving tissue repair, collagen, inflammation, and skin health